Another beneficial effect of rituximab on refractory ANCA-associated vasculitis

The role of interleukin-17 suppression?

S. J. Park, Jaeil Shin

Research output: Contribution to journalLetter

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)221
Number of pages1
JournalScandinavian Journal of Immunology
Volume77
Issue number3
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Murine-Derived Monoclonal Antibodies
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Th17 Cells
Interleukin-17
Immunologic Factors
Rituximab

All Science Journal Classification (ASJC) codes

  • Immunology

Cite this

@article{5ffba444a6ce45bb9eeafda8349297e9,
title = "Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: The role of interleukin-17 suppression?",
author = "Park, {S. J.} and Jaeil Shin",
year = "2013",
month = "3",
day = "1",
doi = "10.1111/sji.12025",
language = "English",
volume = "77",
pages = "221",
journal = "Scandinavian Journal of Immunology",
issn = "0300-9475",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Another beneficial effect of rituximab on refractory ANCA-associated vasculitis

T2 - The role of interleukin-17 suppression?

AU - Park, S. J.

AU - Shin, Jaeil

PY - 2013/3/1

Y1 - 2013/3/1

UR - http://www.scopus.com/inward/record.url?scp=84875630906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875630906&partnerID=8YFLogxK

U2 - 10.1111/sji.12025

DO - 10.1111/sji.12025

M3 - Letter

VL - 77

SP - 221

JO - Scandinavian Journal of Immunology

JF - Scandinavian Journal of Immunology

SN - 0300-9475

IS - 3

ER -